Nicotinic ganglionic acetylcholine receptor autoantibodies associated with paraneoplastic disease in a neuropsychiatric patient

Catherine Stauffer, Daniel A. Llano, Suzanna Kitten

Research output: Contribution to journalArticlepeer-review

Abstract

Nicotinic ganglionic acetylcholine receptor autoantibodies (alpha-3-AChR Ab) are associated with paraneoplastic syndromes when present in low elevations. These antibodies can be tested for as part of an autoimmune encephalopathy panel in neuropsychiatric patients; a mildly elevated titre of alpha-3-AChR Ab that may start as an incidental finding can lead to the diagnosis of a previously undetected cancer. While alpha-3-AChR Ab are most typically associated with thymomas and small cell lung cancer, the presence of these antibodies can suggest a diverse range of other cancers. This case presents a patient with longstanding neuropsychiatric symptoms and possible functional hypothyroidism for whom a low elevation in alpha-3-AChR Ab led to the finding of papillary thyroid carcinoma.

Original languageEnglish (US)
Article number240824
JournalBMJ Case Reports
Volume14
Issue number5
DOIs
StatePublished - May 27 2021
Externally publishedYes

Keywords

  • anxiety disorders (including OCD and PTSD)
  • endocrine cancer
  • mood disorders (including depression)
  • neuroendocrinology
  • screening (oncology)

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Nicotinic ganglionic acetylcholine receptor autoantibodies associated with paraneoplastic disease in a neuropsychiatric patient'. Together they form a unique fingerprint.

Cite this